How big is the Glioblastoma Multiforme Treatment Market?

The Glioblastoma Multiforme Treatment Market size is expected to reach USD 2.80 billion in 2024 and grow at a CAGR of 8% to reach USD 4.60 billion by 2029. Read More

What is the current Glioblastoma Multiforme Treatment Market size?

In 2024, the Glioblastoma Multiforme Treatment Market size is expected to reach USD 2.80 billion. Read More

Who are the key players in Glioblastoma Multiforme Treatment Market?

Arbor Pharmaceuticals, LLC, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd. are the major companies operating in the Glioblastoma Multiforme Treatment Market. Read More

Which is the fastest growing region in Glioblastoma Multiforme Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Glioblastoma Multiforme Treatment Market?

In 2024, the North America accounts for the largest market share in Glioblastoma Multiforme Treatment Market. Read More

What years does this Glioblastoma Multiforme Treatment Market cover, and what was the market size in 2023?

In 2023, the Glioblastoma Multiforme Treatment Market size was estimated at USD 2.58 billion. The report covers the Glioblastoma Multiforme Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Glioblastoma Multiforme Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Glioblastoma Multiforme Treatment Companies

This report lists the top Glioblastoma Multiforme Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Glioblastoma Multiforme Treatment industry.